Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus

Lignende værker

• Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis
  af: Okada, Morihiro, et al.
  Udgivet: (2017)
• Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
  af: Tosaka, Yuka, et al.
  Udgivet: (2015)
• Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy
  af: Langer, Jakob, et al.
  Udgivet: (2019)
• A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study)
  af: Shimoda, Seiya, et al.
  Udgivet: (2016)
• Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose‐lowering effects
  af: Haahr, Hanne, et al.
  Udgivet: (2016)